An update on the management of low-risk differentiated thyroid cancer

L Lamartina, S Leboulleux, M Terroir… - Endocrine-related …, 2019 - erc.bioscientifica.com
Low-risk papillary cancers, which represent the vast majority of thyroid cancers diagnosed
today, do not require aggressive treatment or follow-up. Initial treatment consists of a total …

Management of low-risk differentiated thyroid cancer

EL Mazzaferri - Endocrine Practice, 2007 - Elsevier
Objective To summarize the definitions of and management recommendations for low-risk
thyroid cancer made by the American and European Thyroid Associations and synthesize …

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective

M Schlumberger, G Berg, O Cohen… - European Journal of …, 2004 - academic.oup.com
Objective Because differentiated (follicular and papillary) thyroid cancer (DTC) may recur
years after initial treatment, the follow-up of patients with DTC is long term. However, this …

Low-risk papillary thyroid cancer: times are changing

A Sitges-Serra - Expert Review of Endocrinology & Metabolism, 2014 - Taylor & Francis
The prevalence of papillary thyroid cancer (PTC), particularly of low-risk PTC (MACIS< 6), is
rising due to the increasingly use of neck imaging techniques, fine-needle aspiration and …

Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low‐risk patients with thyroid cancer with Tg on T4< 1 ng/ml determined by …

PW Rosario, S Purisch - Clinical Endocrinology, 2008 - Wiley Online Library
Objective To evaluate a highly sensitive thyroglobulin (Tg) assay [functional sensitivity (FS):
0· 1 ng/ml](Tg‐ICMA) in low‐risk patients with known Tg on T4≤ 1 ng/ml measured by a …

Nonoperative management of low-risk differentiated thyroid carcinoma

Y Ito, A Miyauchi - Current opinion in oncology, 2015 - journals.lww.com
Nonoperative management of low-risk differentiated thyroid c... : Current Opinion in Oncology
Nonoperative management of low-risk differentiated thyroid carcinoma : Current Opinion in …

Current therapeutic options for low‐risk papillary thyroid carcinoma: Scoping evidence review

A Sanabria, P Pinillos, RB Lira, JP Shah… - Head & …, 2022 - Wiley Online Library
Most cases of thyroid carcinoma are classified as low risk. These lesions have been treated
with open surgery, remote access thyroidectomy, active surveillance, and percutaneous …

Management of patients with low-risk papillary thyroid carcinoma

ID Hay - Endocrine Practice, 2007 - Elsevier
Objective To define a rational, cost-effective, simple approach to managing most patients
with papillary thyroid cancer (PTC) who are at low-risk of either cause-specific mortality or …

Changing management in patients with papillary thyroid cancer

DM Elaraj, OH Clark - Current treatment options in oncology, 2007 - Springer
Opinion statement The incidence of thyroid cancer has been increasing over the past 30
years, and it is now the seventh most common cancer in women. Papillary thyroid cancer is …

Papillary thyroid cancer: medical management and follow-up

RT Kloos - Current treatment options in oncology, 2005 - Springer
Opinion statement The incidence of epithelial derived thyroid cancer (papillary thyroid
cancer [PTC] and follicular thyroid cancer, known collectively as differentiated thyroid …